SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alfacell (ACEL)
ACEL 11.54-0.9%Jan 16 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom Scozzafava who wrote (1393)6/20/1998 5:18:00 PM
From: Fish  Read Replies (2) of 1533
 
Tom, I look at Gails's action quite different from you. I think Gail has been acting quite ethically and is doing an excellent job in her position. Moreover, she is certainly not perpetuating a fraud. What Gail has done is raise just enough capital to keep the company going so that the Phase 3 studies may be completed to their logical end. At that time, the results of the studies can be definitively interpreted.

Gail has assembled a credible BOD that can give input with little monetary return. She has also not wasted money on unneeded PR. Moreover, she has not abandoned ship prematurely. Morevoer, she has even hinted that the results of the Phase 3 study may not be efficacious. I believe this was posted several months ago.

In other words, her tenure at Alfacell may in the long run demonstrate her loyalty and ethical responsibility.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News